A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer
1998

Predicting Response to Chemotherapy in Advanced Breast Cancer

Sample size: 173 publication Evidence: moderate

Author Information

Author(s): J Sjostrom, S Krajewski, K Franssila, E Niskanen, V-M Wasenius, S Nordling, JC Reed, C Blomqvist

Primary Institution: Helsinki University Central Hospital

Hypothesis

The study aimed to identify factors that could predict response to chemotherapy in breast cancer.

Conclusion

The study identified three factors—S-phase fraction, grade, and Bax—that independently predicted response to chemotherapy in advanced breast cancer.

Supporting Evidence

  • S-phase fraction was the most powerful predictive factor for chemotherapy response.
  • Low-grade tumors surprisingly responded better to chemotherapy.
  • Bax expression was associated with better chemotherapy response.

Takeaway

Doctors can use certain tumor characteristics to figure out which breast cancer patients will respond well to chemotherapy, helping to avoid unnecessary treatment for others.

Methodology

A randomized trial with 173 patients receiving chemotherapy, followed by multivariate analysis of tumor biological factors.

Limitations

The study had exclusions due to unrepresentative histology and other malignancies, which may limit the generalizability of the findings.

Participant Demographics

Patients with measurable or evaluable metastatic breast cancer, with a history of previous cytotoxic treatment excluded.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication